FDA Investigator Tamala P Bogan

Tamala P Bogan has conducted inspections on 22 sites in 2 countries as of 23 Apr 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
22
Last Inspection Date:
23 Apr 2013
Investigator Role:
FDA Investigation Participant
Redica ID:
100006163
Countries of Inspections:
Switzerland, United States of America
FDA Investigators that have inspected at least one site in common with Tamala P Bogan:
Alan P Kurtzberg, Alexandra B Pitkin, Amanda L Fyles, Amir Alavi, Anderson, Arsen Karapetyan, Ashar P Parikh, Babajide Michael Osunsanmi, Barbara J Rincon, Bichsa T Tran, Binh T Nguyen, Bonnie I Needleman, Brian P Putz, Brien C Fox, Carla J Lundi, Carolina D Vasquez, Carrie A Hughes, Caryn M Mcnab, Cathleen A Carr Sharpe, Celena Ngo, Charles I Ann, Chelsea N Sealey, Christina K Theodorou, Claudia Mperez Kasmarski, Comyar Shoghi, Creighton T Tuzon, Crystal Monroy, Cynthia Jim, CSO, Daniel J Roberts, Darren S Brown, David H Hsu, David Serrano, Deborah A Greco, Deborah M Trout, Decarlos A Gomez, Diana M Rand, Diane Cvan Leeuwen, Djamila Harouaka, Dogbeda F Mackenzie, Donna Ltartaglino Besone, Donna Mwilliams Hill, PhD, Dr. Chunchang Fang, Durell L Giles, Dyana K Stone, Elizabeth A Brown, Elizabeth Ad Girard, Esther B Gamallo Herrera, Gabriel Craig, Gary R Wong, Gavin T Cua, Gene D Arcy, Heidy C Perales, Helen B Ricalde, Himanshu Gupta, PhD, Homero W Aguilar, Hossein Khorshidi, PhD, Iris C Macinnes, Jacqueline Mdiaz Albertini, Jai P Singh, James B Arnett, James M Timper Jr, James P Stumpff, James R Fleckenstein, Jane S Wernberg, Jeff M Uriarte, Jeffery A Johnson, Jeffrey P Raimondi, Jennifer M Gogley, Jenny L Chisem, Jenny L Mccardell, Jessica L Pressley, Jinnie Kokiatkulkij, Jocelyn E Massey, Joel D Hustedt, Joey V Quitania, John A Gonzalez, John P Jorgensen, Jolanna A Norton, Joseph George, Juanita Banuelos, Judy C Nepsa, Katherine E Jacobitz, Kathy Chiu, Kathy Kuo, Keeshunna D Daniels, Kelley, Kelvin Cheung, Kelvin X Sanders, Kenneth H Williams, Kham Phommachanh, Kim Lthomas Cruse, Kirsten S Tharp, Kouros Kangarli, Kristin M Abaonza, Lakecha N Lewis, Lauren L Vajo, Leonard H Lavi, Lillian S Wu, Lilly O Barton, Linda F Murphy, Linda Thai, Ling Yu L Liu, Louis B Cencetti, LT Richard A Lyght, Malgorzata G Norton, PhD, Marcus F Yambot, Mariza M Jafary, Mark C Saale, Mark W Babbitt, Michael D Garcia, Michael F Schuette, Michael T Cyrus, Mihaly S Ligmond, Minh D Phan, Nancy E Byerly, Nancy T Waites, Nga T Ho, Nianna C Burns, Nicholas L Hunt, Nobuko H Katagiri, Olga Simakova, PhD, Omotunde O Osunsanmi, Paula A Trost, Peng Zhou, Philip F Istafanos, DMV, MS, Prabhu P Raju, Rachel C Stanton, Raymond W Brullo, Richard Heath Coats, Richmond K Yip, Robert C Coleman, Robert Jennings, Roger F Zabinski, Ryan J Borges, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sarah A Hassas, Scott T Ballard, Sean P Desbrow, Selene T Torres, Shafiq S Ahadi, Sonya L Karsik, RAC, Srinivas R Chennamaneni, PhD, Stacie A Woods, Stephanie A Slater, MS, Sue Lee Chan, Sundy V Sedwick, Sunitha K Rajaram, PhD, Taichun Qin, PhD, Tamala P Magee, Terri L Dodds, Thao T Kwan, Tiara Nbrown Crosen, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vashti E Bocker, Victor H Loo, Vijaya L Simhadri, Virgilio F Pacio, CSO, Walden H Lee, William S Vitale, Wr Bowman, Xiaohui Shen, Yvonne Y Wu, Zachary A Bogorad

Tamala P Bogan's Documents

Publish Date Document Type Title
May, 2002 EIR Amphastar Pharmaceuticals, Inc. - EIR, 2002-05-02
April, 2006 FDA 483 DLC Laboratories, Inc. - Form 483, 2006-04-12
February, 2005 FDA 483 Response C&E GP Specialists Inc. - Form 483R, 2005-02-22
June, 2002 FDA 483 SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2002-06-26
October, 2002 EIR PACKAGING ADVANTAGE CORP - EIR, 2002-10-15
April, 2013 EIR SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - EIR, 2013-04-23
April, 2000 EIR Constant Irwindale Inc. - EIR, 2000-04-28
September, 2001 FDA 483 Polypeptide Laboratories, Inc. - Form 483, 2001-09-26
February, 2005 FDA 483 C&E GP Specialists Inc. - Form 483, 2005-02-08
March, 2001 FDA 483 Genlabs Corporation - Form 483, 2001-03-19
July, 2000 FDA 483 Response NBTY Acquisition LLC - Form 483R, 2000-07-31
November, 2002 FDA 483 The Belport Company, Inc DBA Gingi-Pak - Form 483, 2002-11-14
February, 2002 EIR Grifols Biologicals LLC - EIR, 2002-02-13
October, 2002 FDA 483 PACKAGING ADVANTAGE CORP - Form 483, 2002-10-15
April, 2000 FDA 483 Anthony Products - Form 483, 2000-04-28
September, 2001 EIR Polypeptide Laboratories, Inc. - EIR, 2001-09-26
October, 2006 FDA 483 Response UFAG Laboratorien AG - Form 483R, 2006-10-23
May, 2002 FDA 483 Amphastar Pharmaceuticals, Inc. - Form 483, 2002-05-02
August, 2003 FDA 483 Medical Chemical Corporation - Form 483, 2003-08-11
January, 2002 FDA 483 Gordon Laboratories - Form 483, 2002-01-08
June, 2002 EIR SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - EIR, 2002-06-26
August, 2000 EIR NBTY Acquisition LLC - EIR, 2000-08-09
July, 2000 FDA 483 Leiner Health Products, Inc. - Form 483, 2000-07-13
October, 2006 EIR UFAG Laboratorien AG - EIR, 2006-10-09
October, 2006 FDA 483 UFAG Laboratorien AG - Form 483, 2006-10-09
May, 2006 FDA 483 Haemonetics Manufacturing, Inc. - Form 483, 2006-05-23
October, 2003 FDA 483 Noli R. Zosa, MD - Form 483, 2003-10-16
March, 2001 EIR Genlabs Corporation - EIR, 2001-03-19
July, 2000 EIR NBTY Acquisition LLC - EIR, 2000-07-13
February, 2006 FDA 483 P & L Development, LLC - Form 483, 2006-02-07
March, 2006 FDA 483 Chemica - Form 483, 2006-03-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more